The Online Investor

Slideshow Secondary Stock Offerings

By The Online Investor Staff, updated Thu., Aug. 6, 5:28 AM

Slide #1. Immunic, Inc. Secondary Offering

Company: Immunic, Inc. (NASDAQ:IMUX)
Date announced: 8/3/2020
Shares Offered: 5,000,000
Secondary Offering Details: Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, today announced that it intends to offer and sell 5 million shares of its common stock in an underwritten public offering. In connection with the offering, the Company intends to grant the underwriters an option for 30 days to purchase up to an additional 750,000 shares of its common stock. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed.

Immunic is a biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. Co. is developing three small molecule products: IMU-838 is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme dihydroorotate dehydrogenase; IMU-935 is an inverse agonist of RORgt; and IMU-856 targets the restoration of the intestinal barrier function. Co.'s main development program, IMU-838, is in Phase 2 clinical development for relapsing-remitting multiple sclerosis and ulcerative colitis, with an additional Phase 2 trial considered in Crohn's disease.
Open the IMUX Page at The Online Investor »

Company Name: 
Immunic Inc
Website: 
www.vitaltherapies.com
Sector: 
Drugs & Pharmaceuticals
Number of ETFs Holding IMUX: 
9
Total Market Value Held by ETFs: 
$2.79M
Total Market Capitalization: 
$220.00M
% of Market Cap. Held by ETFs: 
1.27%
 

Open the IMUX Page at The Online Investor (in a new window) »

List of Secondary Stock Offerings in this Slideshow:

7/20/2020:
Company: CytoSorbents Corporation (CTSO)
Shares Offered: 5,263,158
More: offering details »

7/21/2020:
Company: CASI Pharmaceuticals, Inc. (CASI)
Shares Offered: 20,000,000
More: offering details »

7/21/2020:
Company: Heartland Express, Inc. (HTLD)
Shares Offered: 3,260,870
More: offering details »

7/21/2020:
Company: VERB Technology Company, Inc. (VERB)
Shares Offered: 10,909,090
More: offering details »

7/22/2020:
Company: INUVO, INC. (INUV)
Shares Offered: 20,000,000
More: offering details »

7/22/2020:
Company: Sangoma Technologies CorporationShares Offered: 30,440,000
More: offering details »

7/23/2020:
Company: AcelRx Pharmaceuticals, Inc. (ACRX)
Shares Offered: 9,433,962
More: offering details »

7/23/2020:
Company: Marathon Patent Group, Inc. (MARA)
Shares Offered: 6,666,667
More: offering details »

7/24/2020:
Company: BioHiTech Global, Inc. (BHTG)
Shares Offered: 4,550,000
More: offering details »

7/27/2020:
Company: WiMi Hologram Cloud Inc. (WIMI)
Shares Offered: 7,560,000
More: offering details »

7/27/2020:
Company: TCR2 Therapeutics Inc. (TCRR)
Shares Offered: 8,000,000
More: offering details »

7/27/2020:
Company: CorMedix Inc. (CRMD)
Shares Offered: 4,444,444
More: offering details »

7/27/2020:
Company: Zentalis Pharmaceuticals, Inc. (ZNTL)
Shares Offered: 4,125,000
More: offering details »

7/27/2020:
Company: BioXcel Therapeutics, Inc. (BTAI)
Shares Offered: 4,000,000
More: offering details »

7/28/2020:
Company: Arcturus Therapeutics Holdings Inc. (ARCT)
Shares Offered: 3,264,151
More: offering details »

7/28/2020:
Company: ESSA Pharma Inc. (EPIX)
Shares Offered: 7,100,000
More: offering details »

7/28/2020:
Company: Sunesis Pharmaceuticals, Inc. (SNSS)
Shares Offered: 52,173,913
More: offering details »

7/29/2020:
Company: Document Security Systems, Inc. (DSS)
Shares Offered: 453,333
More: offering details »

7/29/2020:
Company: Salarius Pharmaceuticals, Inc. (SLRX)
Shares Offered: 4,461,209
More: offering details »

7/29/2020:
Company: Tenable (TENB)
Shares Offered: 8,000,000
More: offering details »

7/31/2020:
Company: VistaGen Therapeutics, Inc. (VTGN)
Shares Offered: 15,625,000
More: offering details »

8/3/2020:
Company: Achieve Life Sciences, Inc. (ACHV)
Shares Offered: 476,187
More: offering details »

8/3/2020:
Company: Kinsale Capital Group, Inc (KNSL)
Shares Offered: 270,000
More: offering details »

8/3/2020:
Company: Senmiao Technology Limited (AIHS)
Shares Offered: 12,000,000
More: offering details »

8/3/2020:
Company: Immunic, Inc. (IMUX)
Shares Offered: 5,000,000
More: offering details »

Quotes delayed 20 minutes



Strong Buy (4.00 out of 4)
91st percentile
(ranked higher than approx. 91% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Secondary Stock Offerings Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2020, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.